Evidence map›Paper›PMID 26755131›Full record

ArticleNature communications2016

Impairment of PARK14-dependent Ca(2+) signalling is a novel determinant of Parkinson's disease.

Qingde Zhou, Allen Yen, Grzegorz Rymarczyk, Hirohide Asai, Chelsea Trengrove, Nadine Aziz, Michael T Kirber, Gustavo Mostoslavsky, Tsuneya Ikezu, Benjamin Wolozin and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
9.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 97 citations in OpenAlex.

  1. Phospholipases: Where Do We Stand?Methods in molecular biology (Clifton, N.J.) · 2027
    Review
  2. Article
  3. Article
  4. Mitochondrial Dysfunction in Genetic and Non-Genetic Parkinson's Disease.International journal of molecular sciences · 2025
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. GABAergic neurons are a key cell type in aFrontiers in neuroscience · 2025
    Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Neurodegenerative Disorders: Spotlight on Sphingolipids.International journal of molecular sciences · 2021
    Review
  18. Insights into Lewy body disease from rare neurometabolic disorders.Journal of neural transmission (Vienna, Austria : 1996) · 2021
    Review
  19. Review
  20. Parkinson's Disease-Related Genes and Lipid Alteration.International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Qingde ZhouDepartment of Medicine, Boston University School of Medicine, Boston, Massachusetts 02118, USA.
Allen YenDepartment of Medicine, Boston University School of Medicine, Boston, Massachusetts 02118, USA.
Grzegorz RymarczykDepartment of Medicine, Boston University School of Medicine, Boston, Massachusetts 02118, USA.
Hirohide AsaiDepartment of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts 02118, USA.
Chelsea TrengroveDepartment of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts 02118, USA.
Nadine AzizDepartment of Medicine, Boston University School of Medicine, Boston, Massachusetts 02118, USA.
Michael T KirberDepartment of Medicine, Boston University School of Medicine, Boston, Massachusetts 02118, USA.
Gustavo MostoslavskyCenter for Regenerative Medicine, Boston University School of Medicine, Boston, Massachusetts 02118, USA.
Tsuneya IkezuDepartment of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts 02118, USA.
Benjamin WolozinDepartment of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts 02118, USA.
Victoria M BolotinaDepartment of Medicine, Boston University School of Medicine, Boston, Massachusetts 02118, USA.
Boston University · US

Funding

Stress Granules and the Biology of TDP-43R01ES020395 · NIEHS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI WOLOZIN, BENJAMIN L · 2012 to 2016
$4.1M
Store-Operated Ca entry and iPLA2 in vascular SMCR01HL071793 · NHLBI · BOSTON MEDICAL CENTER · PI BOLOTINA, VICTORIA M · 2003 to 2012
$3.9M
RNA binding proteins as novel targets in Alzheimer's diseaseR01AG050471 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI WOLOZIN, BENJAMIN L · 2015 to 2019
$2.9M
The role of acetylation in regulating pathophysiology of tauR01NS089544 · NINDS · MAYO CLINIC JACKSONVILLE · PI PETRUCELLI, LEONARD, WOLOZIN, BENJAMIN L · 2014 to 2018
$1.9M
LRRK2 and NeurodegenerationR01NS060872 · NINDS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI WOLOZIN, BENJAMIN L · 2009 to 2013
$1.9M
NHLBI NIH HHS R01 HL071793NHLBI NIH HHS R01HL71793NIA NIH HHS R01 AG050471NIEHS NIH HHS R01 ES020395NINDS NIH HHS R01 NS060872NINDS NIH HHS R01 NS089544
6 · The paper itself

Abstract

The etiology of idiopathic Parkinson's disease (idPD) remains enigmatic despite recent successes in identification of genes (PARKs) that underlie familial PD. To find new keys to this incurable neurodegenerative disorder we focused on the poorly understood PARK14 disease locus (Pla2g6 gene) and the store-operated Ca(2+) signalling pathway. Analysis of the cells from idPD patients reveals a significant deficiency in store-operated PLA2g6-dependent Ca(2+) signalling, which we can mimic in a novel B6.Cg-Pla2g6(ΔEx2-VB) (PLA2g6 ex2(KO)) mouse model. Here we demonstrate that genetic or molecular impairment of PLA2g6-dependent Ca(2+) signalling is a trigger for autophagic dysfunction, progressive loss of dopaminergic (DA) neurons in substantia nigra pars compacta and age-dependent L-DOPA-sensitive motor dysfunction. Discovery of this previously unknown sequence of pathological events, its association with idPD and our ability to mimic this pathology in a novel genetic mouse model opens new opportunities for finding a cure for this devastating neurodegenerative disease.

Indexed as

MovementAgedAnimalsBlotting, WesternBrainCalcium SignalingDopaminergic NeuronsFibroblastsGroup VI Phospholipases A2HumansInduced Pluripotent Stem CellsMiceMice, TransgenicMicroscopy, ConfocalMicroscopy, FluorescenceMiddle AgedGroup VI Phospholipases A2PLA2G6 protein, humanPla2g6 protein, mouse

Identifiers

PMID26755131
PMCPMC4729940
OpenAlexW2262997523

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.